neulasta

Neulasta is a brand name for the drug pegfilgrastim. It is a medication used to help people who are receiving certain types of chemotherapy. Chemotherapy can lower the number of white blood cells in the body, which are important for fighting infection. Neulasta works by stimulating the bone marrow to produce more white blood cells, specifically neutrophils. This helps to reduce the risk of febrile neutropenia, a serious condition where a person has a fever and a low white blood cell count.

Neulasta is administered as a subcutaneous injection, meaning it is injected just under the skin. It is typically given once per chemotherapy cycle, usually after the chemotherapy has been completed. The dosage and timing of Neulasta are determined by a healthcare professional based on the individual's chemotherapy regimen and other factors. It is important to follow the doctor's instructions carefully. Side effects can occur and may include bone pain, headache, and fatigue. Patients should report any severe or persistent side effects to their doctor. Neulasta is not intended to treat the cancer itself but rather to manage a side effect of cancer treatment.